Show Nav →

Overview Data source: UniProt

Official Gene Symbol Other Aliases
AMBP HCP,ITIL
Sequence Length (AA) Molecular Weight (Da)
352 38999
Protein Name
Protein AMBP
Sources
UniProt
PhosphoSitePlus ®
GeneCards
Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MRSLGALLLL LSACLAVSAG PVPTPPDNIQ VQENFNISRI YGKWYNLAIG
60 70 80 90 100
STCPWLKKIM DRMTVSTLVL GEGATEAEIS MTSTRWRKGV CEETSGAYEK
110 120 130 140 150
TDTDGKFLYH KSKWNITMES YVVHTNYDEY AIFLTKKFSR HHGPTITAKL
160 170 180 190 200
YGRAPQLRET LLQDFRVVAQ GVGIPEDSIF TMADRGECVP GEQEPEPILI
210 220 230 240 250
PRVRRAVLPQ EEEGSGGGQL VTEVTKKEDS CQLGYSAGPC MGMTSRYFYN
260 270 280 290 300
GTSMACETFQ YGGCMGNGNN FVTEKECLQT CRTVAACNLP IVRGPCRAFI
310 320 330 340 350
QLWAFDAVKG KCVLFPYGGC QGNGNKFYSE KECREYCGVP GDGDEELLRF
352
SN

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node
to view detailed assay information below
All other points link out to UniProt



Phosphorylation Acetylation Ubiquitylation Other

loading

Loader

Assay Details for non-CPTAC-1153 Collapse assay details

Data source: Panorama

Official Gene Symbol
AMBP
Peptide Sequence
ETLLQDFR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
159
Peptide End
166
CPTAC ID
non-CPTAC-1153
Peptide Molecular Mass
1,020.5240
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
plasma
Submitting Laboratory
UVic-Genome BC Proteomics Centre
Submitting Lab PI
Christoph Borchers

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
6490 Triple Quad (Agilent)
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
1290 LC (Agilent)
Column Packing
Zorbax Eclipse Plus C18, 1.8 µm
Column Dimensions
2.1 x 150 mm
Flow Rate
400 µL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
b3 (1+) 12.2 7.3 4.3 12.8 6.2 4 17.7 9.6 5.9 15 15 15
y6 (2+) 8.8 5.7 7.1 12.1 3.5 6.5 15 6.7 9.6 15 15 15
y3 (1+) 7.1 5.1 5.9 11.1 7 5.9 13.2 8.7 8.3 15 15 15
y4 (1+) 4 5.2 5.1 8.6 6.3 6.1 9.5 8.2 8 15 15 15
y5 (1+) 7.5 4.6 3.7 6 5.4 3.8 9.6 7.1 5.3 15 15 15
sum 3.8 3.8 2.5 7.1 4.7 3.4 8.1 6 4.2 15 15 15

Additional Resources and Comments


Assay Details for non-CPTAC-1152 Collapse assay details

Data source: Panorama

Official Gene Symbol
AMBP
Peptide Sequence
HHGPTITAK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
141
Peptide End
149
CPTAC ID
non-CPTAC-1152
Peptide Molecular Mass
960.5141
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
plasma
Submitting Laboratory
UVic-Genome BC Proteomics Centre
Submitting Lab PI
Christoph Borchers

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
6490 Triple Quad (Agilent)
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
1290 LC (Agilent)
Column Packing
Zorbax Eclipse Plus C18, 1.8 µm
Column Dimensions
2.1 x 150 mm
Flow Rate
400 µL/min

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
b3 (1+) 8.2 5.3 5.8 11.8 10.3 14.6 14.4 11.6 15.7 15 15 15
b2 (1+) 7.5 7.3 6.9 12 10.4 11.2 14.2 12.7 13.2 15 15 15
y6 (3+) NA NA NA NA NA NA NA NA NA 0 0 0
y2 (1+) 10.2 2.7 3.6 13.4 4.6 5.6 16.8 5.3 6.7 15 15 15
y3 (1+) 6.4 4.8 6.1 8.7 6.1 7.6 10.8 7.8 9.7 15 15 15
sum 3.6 3.7 2.9 6.3 4.9 3.6 7.3 6.1 4.6 15 15 15

Additional Resources and Comments